TSCAN THERAPEUTICS INC
TCRXNASDAQ🏆 #3670 by market capUS Equity
$0.77▼ $0.00 (−0.42%)
Market closed · at close1h—
24h▼ 0.4%
7d—
14d—
30d—
1y—
🏦Market Cap
$51M
Small Cap
📈Revenue Growth (YoY)
+106.7%
High Growth
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
5.5x
Fair
Otter Score
59
Weak
Earnings
Q2 · 2026Reported 2026-05-06Earnings Per Share
Actual
-0.22
Expected
-0.22
inline
+0.00%
YoY +15.40%
Revenue
Actual
$982.00K
Expected
$2.50M
miss
−60.70%
YoY −54.80%
Consensus estimates
Recent quarters
Q2 2026
-0.22
inline
Q1 2026
-0.18
beat
Q4 2025
-0.28
beat
Q3 2025
-0.28
inline